What is MacroGenics Inc (MGNX) stock price today?

MacroGenics Inc (MGNX) currently trades at $3.08 per share. The stock has a market capitalization of $193.86M and a P/E ratio of —x.

Is MGNX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MacroGenics Inc has a Smart Value Score of 43/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is MacroGenics Inc's revenue and earnings?

MacroGenics Inc has trailing twelve-month (TTM) revenue of $149.50M with profit margins of -49.90%. Earnings per share (EPS) is $-1.18.

MGNX

MacroGenics Inc

NASDAQ: MGNX · HEALTHCARE · BIOTECHNOLOGY

$3.08

+4.76% today

Updated 2026-04-30

Market cap

$193.86M

P/E ratio

—

P/S ratio

1.30x

EPS (TTM)

$-1.18

Dividend yield

—

52W range

$1 – $4

Volume

1.1M

Market cap

$193.86M

P/E ratio

—

P/S ratio

1.30x

EPS (TTM)

$-1.18

Dividend yield

—

52W range

$1 – $4

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.20

+68.83%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy5 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $42.78M — positive

+ Revenue growth 113.00% QoQ

Risks

- Thin margins at -49.90%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$151.94M	$57.19M	$148.34M	$149.50M	$149.50M
Net income	$-120.02M	$-9.06M	$-66.97M	$-74.62M	$-14.15M
EPS	—	—	—	—	$-1.18
Free cash flow	$-90.58M	$-79.97M	$-72.08M	$-82.95M	$42.78M
Profit margin	-78.99%	-15.84%	-45.14%	-49.91%	-49.90%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MGNX	$193.86M	43	4.7	2.0	6.7	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MacroGenics Inc trades at $3.08. Our Smart Value Score of 43/100 indicates the stock is fair. TTM revenue stands at $149.50M. with profit margins at -49.90%.

Frequently asked questions

What is MacroGenics Inc's stock price?

MacroGenics Inc (MGNX) trades at $3.08.

Is MacroGenics Inc overvalued?

Smart Value Score 43/100 (Grade D, Sell).

What is the price target of MacroGenics Inc (MGNX)?

The analyst target price is $5.20, representing +68.8% upside from the current price of $3.08.

What is MacroGenics Inc's revenue?

TTM revenue is $149.50M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.30x

ROE-87.00%

Beta1.10

50D MA$2.78

200D MA$1.92

Shares out0.06B

Float0.06B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MGNX vs LLY →MGNX vs JNJ →MGNX vs ABBV →Stock screener →